Company
Voyager Therapeutics
Voyager Therapeutics has 3 drugs tracked on RxWires: 1 in Phase 1/2, 2 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| VY7523 | Phase 1/2 | Alzheimer's Disease (AD) |
| Intraparenchymal rAAV1 - (mi)RNA HTT | Phase 1 | Huntington Disease |
| VY1706 Low dose | Phase 1 | Alzheimer s Disease |
Latest
- voyager therapeutics filed 8-K
- voyager therapeutics filed 8-K
- voyager therapeutics filed 8-K
- Licensing / Collaboration Deal: voyager therapeutics
- voyager therapeutics filed 8-K
Follow Voyager Therapeutics on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.